Search Results - "LAMPERTI, C"

Refine Results
  1. 1

    AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome by Di Meo, I, Marchet, S, Lamperti, C, Zeviani, M, Viscomi, C

    Published in Gene therapy (01-10-2017)
    “…Leigh syndrome (LS) is the most common infantile mitochondrial encephalopathy. No treatment is currently available for this condition. Mice lacking Ndufs4 ,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Adult-onset mitochondrial movement disorders: a national picture from the Italian Network by Montano, V., Orsucci, D., Carelli, V., La Morgia, C., Valentino, M. L., Lamperti, C., Marchet, S., Musumeci, O., Toscano, A., Primiano, G., Santorelli, F. M., Ticci, C., Filosto, M., Rubegni, A., Mongini, T., Tonin, P., Servidei, S., Ceravolo, R., Siciliano, G., Mancuso, Michelangelo

    Published in Journal of neurology (01-03-2022)
    “…Introduction Both prevalence and clinical features of the various movement disorders in adults with primary mitochondrial diseases are unknown. Methods Based…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Clinicopathological features of genetically confirmed Danon disease by SUGIE, K, YAMAMOTO, A, LAMPERTI, C, SAITOH, S, BYRNE, E, DIMAURO, S, NONAKA, I, HIRANO, M, NISHINO, I, MURAYAMA, K, OH, S. J, TAKAHASHI, M, MORA, M, RIGGS, J. E, COLOMER, J, ITURRIAGA, C, MELONI, A

    Published in Neurology (25-06-2002)
    “…Danon disease is due to primary deficiency of lysosome-associated membrane protein-2. To define the clinicopathologic features of Danon disease. The features…”
    Get full text
    Journal Article
  8. 8

    Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction by DEL BO, R, MOGGIO, M, LAMPERTI, C, CORTI, S, FEDERICO, A, BRESOLIN, N, COMI, G. P, RANGO, M, BONATO, S, D'ANGELO, M. G, GHEZZI, S, AIROLDI, G, BASSI, M. T, GUGLIERI, M, NAPOLI, L

    Published in Neurology (09-12-2008)
    “…The axonal forms of Charcot-Marie-Tooth (CMT2) disease are a clinically and genetically heterogeneous group of disorders. Mitofusin 2 gene (MFN2) mutations are…”
    Get full text
    Journal Article
  9. 9

    Cerebellar ataxia and coenzyme Q10 deficiency by LAMPERTI, C, NAINI, A, DUBROVSKY, T, CHIRIBOGA, C, ANGELINI, C, PEGORARO, E, DIMAURO, S, HIRANO, M, DE VIVO, D. C, BERTINI, E, SERVIDEI, S, VALERIANI, M, LYNCH, D, BANWELL, B, BERG, M

    Published in Neurology (08-04-2003)
    “…The authors measured coenzyme Q10 (CoQ10) concentration in muscle biopsies from 135 patients with genetically undefined cerebellar ataxia. Thirteen patients…”
    Get full text
    Journal Article
  10. 10

    Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency by Corti, S, Bordoni, A, Ronchi, D, Musumeci, O, Aguennouz, M, Toscano, A, Lamperti, C, Bresolin, N, Comi, G.P

    Published in Journal of the neurological sciences (15-03-2008)
    “…Abstract Carnitine palmitoyltransferase II (CPT II) deficiency is the most common inherited disorder of lipid metabolism characterized in its adult form by…”
    Get full text
    Journal Article
  11. 11

    Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk by Lamperti, C, Zeviani, M

    Published in Acta myologica (01-07-2009)
    “…Autosomal dominant Progressive External Ophthalmoplegias are Mendelian disorders characterized by the accumulation of multiple deletions of mitochondrial DNA…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    New molecular findings in congenital myopathies due to selenoprotein N gene mutations by Cagliani, R, Fruguglietti, M.E, Berardinelli, A, D'Angelo, M.G, Prelle, A, Riva, S, Napoli, L, Gorni, K, Orcesi, S, Lamperti, C, Pichiecchio, A, Signaroldi, E, Tupler, R, Magri, F, Govoni, A, Corti, S, Bresolin, N, Moggio, M, Comi, G.P

    Published in Journal of the neurological sciences (15-01-2011)
    “…Abstract Selenoprotein N-related myopathy (SEPN1-RM) is an early-onset muscle disorder that can manifest clinically as congenital muscular dystrophy with…”
    Get full text
    Journal Article
  15. 15

    Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency by GIRONI, M, LAMPERTI, C, DIMAURO, S, NEMNI, R, MOGGIO, M, COMI, G, GUERINI, F. R, FERRANTE, P, CANAL, N, NAINI, A, BRESOLIN, N

    Published in Neurology (09-03-2004)
    “…Two brothers had late-onset progressive ataxia, cerebellar atrophy, and hypergonadotropic hypogonadism associated with coenzyme Q10 (CoQ10) deficiency in…”
    Get full text
    Journal Article
  16. 16

    T.P.18 by Sciacco, M, Ronchi, D, Ripolone, M, Violano, R, Lucchini, V, Xhani, R, Comi, G.P, Fortunato, F, Bordoni, A, Tonin, P, Filosto, M, Previtali, S, Mongini, T, Vercelli, L, Vittonatto, E, Toscano, A, Musumeci, O, Barca, E, Angelini, C, Lamperti, C, Mora, M, Morandi, L, Moggio, M

    Published in Neuromuscular disorders : NMD (01-10-2014)
    “…Glycogenosis type II (OMIM 23230) is an autosomal recessive lysosomal storage disorder resulting from a deficiency in the glucosidase alpha acid (GAA) enzyme…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    A CAV3 microdeletion differentially affects skeletal muscle and myocardium by Cagliani, R, Bresolin, N, Prelle, A, Gallanti, A, Fortunato, F, Sironi, M, Ciscato, P, Fagiolari, G, Bonato, S, Galbiati, S, Corti, S, Lamperti, C, Moggio, M, Comi, G P

    Published in Neurology (09-12-2003)
    “…Caveolin-3 is the muscle-specific protein product of the caveolin gene family and an integral membrane component of caveolae. Mutations in the gene encoding…”
    Get full text
    Journal Article
  20. 20